Physician Wealth Advisors’s BridgeBio Pharma BBIO Stock Holding History

Physician Wealth Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9K	Buy	39 +8	+26%	+$560	﹤0.01%	1351
2026 Q1	$2.3K	Hold	31	–	–	﹤0.01%	1288
2025 Q4	$2.37K	Buy	31 +6	+24%	+$394	﹤0.01%	1216
2025 Q3	$1.3K	Buy	25 +14	+127%	+$683	﹤0.01%	1424
2025 Q2	$475	Buy	+11	New	+$400	﹤0.01%	1730

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Physician Wealth Advisors's BBIO Position: Q2 2026 in Review

Physician Wealth Advisors increased its BridgeBio Pharma (BBIO) stake by 26% in Q2 2026, buying an estimated $560 and bringing the position to 39 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Physician Wealth Advisors first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Physician Wealth Advisors held 39 shares of BridgeBio Pharma worth $2.9K as of Q2 2026.
Physician Wealth Advisors bought 8 BridgeBio Pharma shares in Q2 2026, an estimated $560.
BridgeBio Pharma made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1351 holding.
Physician Wealth Advisors first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.